$OPGN catalyst: FDA decision Acuitas AMR Gene Panel

Hyping on twitter: Added New position $OPGN primarily for the top catalyst FDA decision Acuitas AMR Gene Panel. In addition, pipeline includes Broad pathogen and Antimicrobial Resistance Marker coverage. 53 M market cap. Eyeing $3.3 breakout target towards $4 plus. Should spike on FDA decision.

twitter.com/Pharmdca.../1358837925039935490